● Recruiting

A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer

Condition: HER2-positive Breast Cancer · Sponsor: GeneQuantum Healthcare (Suzhou) Co., Ltd.

PhasePhase 3

Planned participants228

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

This study is designed to compare efficacy and safety of GQ1005 versus T-DM1 in HER2-positive, unresectable and/or metastatic breast cancer patients previously treated with trastuzumab and taxane.

This description comes directly from the study's public registry record.

Talk to the study team

Zhenxing Yang · +86 13801896162 · yangzx@genequantum.com

Always discuss trial participation with your own doctor first.

Locations (70)

The First Affiliated Hospital of Bengbu Medical University	Bengbu, Anhui, China	Recruiting
The Affiliated Fuyang Hospital of Anhui Medical University	Fuyang, Anhui, China	Recruiting
The First Affiliated Hospital of Anhui Medical University	Hefei, Anhui, China	Recruiting
Anhui Cancer Hospital	Hefei, Anhui, China	Recruiting
The Fifth Medical Center of the Chinese People's Liberation Army General Hospital	Beijing, Beijing Municipality, China	Recruiting
Chongqing University Cancer Hospital	Chongqing, Chongqing Municipality, China	Recruiting
Fujian Cancer Hospital	Fuzhou, Fujian, China	Recruiting
The Second Affiliated Hospital of Fujian Medical University	Quanzhou, Fujian, China	Recruiting
Sun Yat-sen University Cancer Center	Guangzhou, Guangdong, China	Recruiting
Sun Yat-sen Memorial Hospital, Sun Yat-sen University	Guangzhou, Guangdong, China	Recruiting
Meizhou People's Hospital	Meizhou, Guangdong, China	Recruiting
Shantou Central Hospital	Shantou, Guangdong, China	Recruiting

+ 58 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07673029